                         SEQUENCE LISTING

<110>  Bar Ilan University
 
<120>  LIPOSOMES FOR MODULATING WISKOTT-ALDRICH SYNDROME PROTEIN

<130>  C025-P1330-PCT

<150>  US 61/830,178
<151>  2013-06-03

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA

<400>  1
ugacugagug gcugaguua                                                    19


<210>  2
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA

<400>  2
gaccuagccc agcugauaa                                                    19


<210>  3
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA

<400>  3
gaauggauuu gacgugaac                                                    19


<210>  4
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA

<400>  4
gccgagaccu cuaaacuua                                                    19


<210>  5
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA

<400>  5
ugagaugcuu ggacgaaaa                                                    19


<210>  6
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA

<400>  6
gaaucagagg caaagugga                                                    19


<210>  7
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA

<400>  7
ucucaguucu cuucacuca                                                    19


<210>  8
<211>  8
<212>  PRT
<213>  Homo sapiens

<400>  8

Cys Pro Asn Lys Glu Lys Glu Cys 
1               5               


<210>  9
<211>  37
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA

<400>  9
uagcgacuaa acacaucaau aggcuaugaa gagauac                                37


<210>  10
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA

<400>  10
auguauuggc cuguauuag                                                    19


<210>  11
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA

<400>  11
augaacguga auugcucaa                                                    19


<210>  12
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  siRNA

<400>  12
ugguuuacau gucgacuaa                                                    19


<210>  13
<211>  63
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment based on WIP

<400>  13

Met Gly Ser Ser His His His His His His Ser Gly Gln Asp Ser Pro 
1               5                   10                  15      


Cys Glu Asp Glu Trp Glu Ser Arg Phe Tyr Phe His Pro Ile Ser Asp 
            20                  25                  30          


Leu Pro Pro Pro Glu Pro Tyr Val Gln Thr Thr Lys Ser Tyr Pro Ser 
        35                  40                  45              


Lys Leu Ala Arg Asn Glu Ser Arg Ser Gly Ser Asn Pro Arg Glu 
    50                  55                  60              


<210>  14
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment based on WIP

<400>  14

Asp Leu Pro Pro Pro Glu Pro Tyr Val Gln Thr Thr Lys Ser Tyr Pro 
1               5                   10                  15      


Ser Lys Leu Ala Arg 
            20      


<210>  15
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment based on WIP

<400>  15

Met Gly Ser Ser His His His His His His Ser Gly Gln Asp Ser Pro 
1               5                   10                  15      


Cys Glu Asp Glu Trp Glu Ser Arg Phe Tyr Phe His Pro Ile Ser Asp 
            20                  25                  30          


Leu Pro Pro Pro Glu Pro Tyr Val Gln Thr Thr Lys Ser Tyr Pro Ser 
        35                  40                  45              


Lys Leu Ala Arg Asn Glu Ser Arg 
    50                  55      


